CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | +7.4% | 1,146 | -60.0% | 0.00% | – |
| Q2 2022 | $68,000 | +6.2% | 2,862 | 0.0% | 0.00% | – |
| Q1 2022 | $64,000 | +12.3% | 2,862 | 0.0% | 0.00% | – |
| Q4 2021 | $57,000 | +1.8% | 2,862 | 0.0% | 0.00% | – |
| Q3 2021 | $56,000 | -11.1% | 2,862 | 0.0% | 0.00% | – |
| Q2 2021 | $63,000 | -7.4% | 2,862 | 0.0% | 0.00% | – |
| Q1 2021 | $68,000 | -29.2% | 2,862 | -22.1% | 0.00% | – |
| Q4 2020 | $96,000 | +50.0% | 3,676 | 0.0% | 0.00% | – |
| Q3 2020 | $64,000 | +3.2% | 3,676 | 0.0% | 0.00% | – |
| Q2 2020 | $62,000 | -62.4% | 3,676 | -73.6% | 0.00% | – |
| Q1 2020 | $165,000 | -1.8% | 13,900 | 0.0% | 0.00% | – |
| Q4 2019 | $168,000 | -53.1% | 13,900 | -45.1% | 0.00% | -100.0% |
| Q3 2019 | $358,000 | -57.7% | 25,300 | -66.7% | 0.00% | – |
| Q2 2019 | $846,000 | +171.2% | 75,900 | +338.7% | 0.00% | -100.0% |
| Q4 2017 | $312,000 | +127.7% | 17,300 | +143.7% | 0.00% | – |
| Q3 2017 | $137,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |